News

Article

bit.bio featured in TechRound list of top University of Cambridge spin outs

The list looks at how companies are performing and what they are working on.

10.02.2022

Published by TechRound

The list looks at how companies are performing and what they are working on.

Published by TechRound

Read now

Article

bit.bio CEO featured in Technology Networks

Technology Networks cover the development, benefits and applications of ioSkeletal Myocytes.

03.02.2022

Published by Technology Networks

Read now

Article

bit.bio CEO featured in TechRound

Founder and CEO Dr Mark Kotter joined the experts who have given their thoughts on what is to come for the health sector in 2022.

31.01.2022

Published by TechRound

Read now

Article

This Startup Is Making — and Programming — Human Cells

Wired spoke to bit.bio's CEO and CMO about reprogramming cells for therapies.

21.12.2021

Published by Wired

Read now

Article

bit.bio CEO features in Charles River's Laboratories Disruptor series

The Charles River's Laboratories Disruptor series celebrates the work of their innovative partners.

30.11.2021

Published by CRL Disruptors

Read now

Article

Takeda oncology vet joins bit.bio as COO

bit.bio Chief Operating Officer Kathryn Corzo featured in Endpoints News.

19.11.2021

Published by Endpoints News

Read now

Press Release

bit.bio appoints Kathryn Corzo as Chief Operating Officer

bit.bio appoints accomplished biotechnology executive and drug developer Kathryn Corzo as Chief Operating Officer.

17.11.2021

Published by bit.bio

Read now

Press Release

bit.bio signs up to race to zero as part of COP26

The pledge is part of our mission to code cells for novel cures and to be a purpose led company.

10.11.2021

Published by bit.bio

Read now

Article

bit.bio adds $100M+ and members to its board of directors

This feature covers the latest fundraise and appointments to the board.

05.11.2021

Published by Endpoints News

Read now

Related pages